Arcellx, Inc.

Arcellx, Inc.verified

ACLX

Price:

$68.45

Market Cap:

$3.79B

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known...[Read more]

Industry

Biotechnology

IPO Date

2022-02-04

Stock Exchange

NASDAQ

Ticker

ACLX

The Enterprise Value as of December 2025 (TTM) for Arcellx, Inc. (ACLX) is 3.78B

According to Arcellx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.78B. This represents a change of -3.97% compared to the average of 3.94B of the last 4 quarters.

Arcellx, Inc. (ACLX) Historical Enterprise Value (quarterly & annually)

How has ACLX Enterprise Value performed in the past?

The mean historical Enterprise Value of Arcellx, Inc. over the last ten years is 1.32B. The current 3.78B Enterprise Value has changed 28.65% with respect to the historical average. Over the past ten years (40 quarters), ACLX's Enterprise Value was at its highest in in the September 2024 quarter at 4.40B. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

1.32B

Median

549.74M

Minimum

-11748239.20

Maximum

4.06B

Arcellx, Inc. (ACLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arcellx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 160.95%

Maximum Annual Enterprise Value = 4.06B

Minimum Annual Increase = -4779.37%

Minimum Annual Enterprise Value = -11748239.20

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20244.06B71.12%
20232.37B70.49%
20221.39B160.95%
2021532.80M66.89%
2020319.25M-41.93%
2019549.74M-4779.37%

Arcellx, Inc. (ACLX) Average Enterprise Value

How has ACLX Enterprise Value performed in the past?

The current Enterprise Value of Arcellx, Inc. (ACLX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.61B

5-year avg

1.73B

10-year avg

1.32B

Arcellx, Inc. (ACLX) Enterprise Value vs. Peers

How is ACLX’s Enterprise Value compared to its peers?

Arcellx, Inc.’s Enterprise Value is less than Alkermes plc (4.29B), greater than NewAmsterdam Pharma Company N.V. (3.52B), less than Akero Therapeutics, Inc. (4.31B), less than Protagonist Therapeutics, Inc. (5.36B), less than Arrowhead Pharmaceuticals, Inc. (9.52B), less than Kymera Therapeutics, Inc. (4.74B), less than Viking Therapeutics, Inc. (4.26B), greater than Immunovant, Inc. (3.49B), less than CRISPR Therapeutics AG (5.11B), less than Vaxcyte, Inc. (5.83B),

Build a custom stock screener for Arcellx, Inc. (ACLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcellx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcellx, Inc. (ACLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcellx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Arcellx, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Arcellx, Inc. (ACLX)?

What is the 3-year average Enterprise Value for Arcellx, Inc. (ACLX)?

What is the 5-year average Enterprise Value for Arcellx, Inc. (ACLX)?

How does the current Enterprise Value for Arcellx, Inc. (ACLX) compare to its historical average?